Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000714

Type of data
NGS (WGS)
Access criteria
Controlled-access (Type I)
Total data volume
488 GB
File formats
  • FASTQ
  • BAM
  • TXT
Research
hum0382
Date published
2023-01-20
Date modified
2023-01-20
DDBJ Search
JGAD000714 (opens in a new tab)
JGA Study
JGAS000587 (opens in a new tab)

Analysis method

WGS

Materials and participants
AML with FUS-ERG (ICD10: C92.0): 1 case
1. bone marrow cells at the first visit for MDS: 1 sample
2. bone marrow cells at that time for AML (relapse): 1 sample
3. oral swab specimen: 1 sample
  • Health status
    Affected
  • Subject count
    1 (Individual)
Disease
AML with FUS-ERG (C920)
Sample description
DNAs extracted from bone marrow mononuclear cells and oral mucosa cells
  • Tissue
    Bone marrow, Oral mucosa
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WGS
Target
N/A
Reagent kit
TruSeq Nano DNA Library Prep Kit
Fragmentation
Ultrasonic fragmentation (Covaris S220)
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp
Reference genome
GRCh37
Mapping
DRAGEN DNA Pipeline
Mapping quality
1. Mapped reads: 83.26%, Unique reads: 77.34%
2. Mapped reads: 94.94%, Unique reads: 89.15%
3. Mapped reads: 95.09%, Unique reads: 85.93%
Analysis method
DRAGEN DNA Pipeline (Somatic Mode [tumor-normal pipeline])
Coverage (depth)
27.96x (Item 1, mean)
54.68x (Item 2, mean)
65.07x (Item 3, mean)
Coverage (breadth)
Pct > 0.2*mean: 97.61% (Item 1)
Pct > 0.2*mean: 97.66% (Item 2)
Pct > 0.2*mean: 97.62% (Item 3)
Data use policy
NBDC data sharing policy (JGAP000001)